Clinical Trial Update: Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 single-arm trial evaluating nimotuzumab with radiotherapy in older patients with esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED